Cannabis Technologies Inc. to List on CSE, Delist from TSX
20 May 2014
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - (previously Meridex Software) is pleased to announce to announce that it has received final approval to list its common shares on the Canadian Securities Exchange (the "CSE"), and has voluntarily delisted its common shares from the TSX Venture Exchange. The company will begin trading on the CSE at market open on May 21, 2014. The Company's trading symbol will be "CAN".
Cannabis Technologies Inc. is a biopharmaceutical company that specializes in developing cannabis-based botanical and non-botanical therapies through the Research and Development into the extensive pharmacology of cannabinoids.
The company will utilize its proprietary to identify new bioactive compounds within the marijuana plant that can treat specific diseases and the genes responsible for those diseases.
Our extensive research and new intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Glaucoma, Cancer & Angiogenesis, inflammation, pain & arthritis. Please visit our website at: www.cannabis-tech.com
Craig Schneider, President and CEO
Forward Looking Statements
These risks and uncertainties include, among others, the possibility that clinical trials will not be successful, or be completed, or confirm earlier clinical trial results, risks associated with obtaining funding from third parties, risks related to the timing and costs of clinical trials and the receipt of regulatory approvals